1. Home
  2. PBH vs AAPG Comparison

PBH vs AAPG Comparison

Compare PBH & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBH
  • AAPG
  • Stock Information
  • Founded
  • PBH 1996
  • AAPG 2009
  • Country
  • PBH United States
  • AAPG China
  • Employees
  • PBH N/A
  • AAPG N/A
  • Industry
  • PBH Biotechnology: Pharmaceutical Preparations
  • AAPG Biotechnology: Pharmaceutical Preparations
  • Sector
  • PBH Health Care
  • AAPG Health Care
  • Exchange
  • PBH Nasdaq
  • AAPG Nasdaq
  • Market Cap
  • PBH 3.3B
  • AAPG 3.6B
  • IPO Year
  • PBH 2005
  • AAPG 2025
  • Fundamental
  • Price
  • PBH $63.06
  • AAPG $39.00
  • Analyst Decision
  • PBH Buy
  • AAPG Buy
  • Analyst Count
  • PBH 5
  • AAPG 1
  • Target Price
  • PBH $94.00
  • AAPG N/A
  • AVG Volume (30 Days)
  • PBH 581.5K
  • AAPG 11.9K
  • Earning Date
  • PBH 11-06-2025
  • AAPG 11-06-2025
  • Dividend Yield
  • PBH N/A
  • AAPG N/A
  • EPS Growth
  • PBH 4.18
  • AAPG N/A
  • EPS
  • PBH 4.26
  • AAPG N/A
  • Revenue
  • PBH $1,120,150,000.00
  • AAPG $54,524,554.00
  • Revenue This Year
  • PBH N/A
  • AAPG N/A
  • Revenue Next Year
  • PBH $2.24
  • AAPG $387.72
  • P/E Ratio
  • PBH $14.66
  • AAPG N/A
  • Revenue Growth
  • PBH 0.63
  • AAPG N/A
  • 52 Week Low
  • PBH $61.93
  • AAPG $16.50
  • 52 Week High
  • PBH $90.04
  • AAPG $48.45
  • Technical
  • Relative Strength Index (RSI)
  • PBH 50.19
  • AAPG N/A
  • Support Level
  • PBH N/A
  • AAPG N/A
  • Resistance Level
  • PBH $66.04
  • AAPG N/A
  • Average True Range (ATR)
  • PBH 1.31
  • AAPG 0.00
  • MACD
  • PBH -2.31
  • AAPG 0.00
  • Stochastic Oscillator
  • PBH 91.86
  • AAPG 0.00

About PBH Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: